Autopsy report · NCT03589781

Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

“Covid 19 Pandemic - Unable to enroll patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Nikkei (Canada) Marketing Limited

Sponsor type

Industry

Conditions

Prostate Cancer

Interventions

Mikei Red Reishi Essence EX; Placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
  “COVID-19 pandemic, unable to enroll participants” (91% match in meaning)
• Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
  “not possible to enroll during COVID pandemic” (83% match in meaning)
• Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity Spasticity
  “unable to enroll patients due to closure of our inpatient units secondary to COVID-19.” (80% match in meaning)
• Nutritional Supplementation in the Elderly With Weight Loss
  “Unable to enroll due to Pandemic” (78% match in meaning)
• Study Evaluating Subjects With Distal Renal Tubular Acidosis
  “COVID-19 pandemic negatively impacted the ability to enroll patients.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.